|
Re: Buy-Out
|
2
|
Resverlogix Corp.
|
Nov 20, 2019 10:45PM
|
|
About that 18% to 21% RRR...
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 06:49PM
|
|
Re: Positives vs. negatives
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 05:54PM
|
|
Re: Positives vs. negatives
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 01:58PM
|
|
Re: New share price contest for end of year 2019
|
11
|
Resverlogix Corp.
|
Nov 20, 2019 10:18AM
|
|
Re: balancing success and failure
|
1
|
Resverlogix Corp.
|
Nov 19, 2019 07:33PM
|
|
Re: New share price contest for end of year 2019
|
|
Resverlogix Corp.
|
Nov 19, 2019 07:06PM
|
|
Re: Hepalink
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 11:05PM
|
|
Re: BETonMACE summary from Webcast 11/18/19
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 02:41PM
|
|
Re: collaboration or financing
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 09:50AM
|
|
This is a Drug for people at the end of their life...CHF and advanced kidney disease...so is Dementia next?
|
8
|
Resverlogix Corp.
|
Nov 18, 2019 09:44AM
|
|
BFW...You were right...this is a kidney disease drug already!
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 09:14AM
|
|
Re: I have the feeling that....
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 08:24AM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 06:53PM
|
|
Re: Estimated Glomerular Filtration Rate
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 05:51PM
|
|
Re: Potential market
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 04:11PM
|
|
About the Monday Presentation
|
7
|
Resverlogix Corp.
|
Nov 17, 2019 12:02AM
|
|
Re: Comments re AHA presentation
|
5
|
Resverlogix Corp.
|
Nov 16, 2019 06:58PM
|
|
Re: Take Home Points: not ready for use in patients
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 05:50PM
|
|
Re: Take Home Points: not ready for use in patients
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 04:33PM
|
